AAAAAA

   
Results: 1-17 |
Results: 17
TREATMENT OF ESTROGEN DEFICIENCY SYMPTOMS IN WOMEN SURVIVING BREAST-CANCER
Authors: ANDERSON T BARDIN CW BARRETTCONNER E BLACK C BORWHAT M BURGER H CLARKSON T COBLEIGH M COSMAN F HAYES H DOUGLAS MS DUNAIF A FORD J GANZ P GLEASON S GOODWIN P GOSS P GREEN B GRETZ E HARVEY J HAZZARD W HELZLSOUER K JORDAN VC JOSSE R KELEGHAN J KLEEREKOPER M LEWIS J LLEWELLYNTHOMAS H LOPRINZI C MARK M MARTIN A MARTIN H MIESFELDT S MOORE M NACHTIGALL L NEW M OCONNOR A OLSEN M PARKER B PARNES H PERLMAN J PINKERTON J POWLES T PRIOR J PRITCHARD K RAGAZ J RAILEY E KOMEN SG RUMEN N ROPKA M ROSS RK SANTEN R SAWKA C SELLIN R SLINGLUFF C SWAIN S TYSENHOUSE P WATTS N WHAMOND E WILLS M
Citation: T. Anderson et al., TREATMENT OF ESTROGEN DEFICIENCY SYMPTOMS IN WOMEN SURVIVING BREAST-CANCER, The Journal of clinical endocrinology and metabolism, 83(6), 1998, pp. 1993-2000
HIGH JUGULAR BULB AND CONDUCTIVE HEARING-LOSS
Authors: WEISS RL ZAHTZ G GOLDOFSKY E PARNES H SHIKOWITZ MJ
Citation: Rl. Weiss et al., HIGH JUGULAR BULB AND CONDUCTIVE HEARING-LOSS, The Laryngoscope, 107(3), 1997, pp. 321-327
SYNTHESIS OF THE H-3 LABELED 5-HT3 ANTAGONIST (RS-25259-197) AT HIGH SPECIFIC ACTIVITY
Authors: GONG LY PARNES H
Citation: Ly. Gong et H. Parnes, SYNTHESIS OF THE H-3 LABELED 5-HT3 ANTAGONIST (RS-25259-197) AT HIGH SPECIFIC ACTIVITY, Journal of labelled compounds & radiopharmaceuticals, 38(5), 1996, pp. 425-433
SYNTHESIS OF (R)-3-AMINOQUINUCLIDINE-[3-C-14] AND (S)-3-AMINOQUINUCLIDINE-[3-C-14] ENANTIOMERS, IMPORTANT COMPONENTS OF A VARIETY OF 5-HT3 LIGANDS
Authors: PARNES H SHELTON EJ
Citation: H. Parnes et Ej. Shelton, SYNTHESIS OF (R)-3-AMINOQUINUCLIDINE-[3-C-14] AND (S)-3-AMINOQUINUCLIDINE-[3-C-14] ENANTIOMERS, IMPORTANT COMPONENTS OF A VARIETY OF 5-HT3 LIGANDS, Journal of labelled compounds & radiopharmaceuticals, 38(1), 1996, pp. 19-29
SUPER HIGH SPECIFIC ACTIVITY TRITIUM-LABELED RECEPTOR LIGANDS .1. THEUSE OF POLYBROMODIPHENYLACETIC ACID AS A TRITIATION SUBSTRATE - SYNTHESIS OF A TRITIUM-LABELED SODIUM-CHANNEL BLOCKER AND ANGIOTENSIN-II ANTAGONIST WITH SUPER HIGH SPECIFIC ACTIVITY
Authors: GONG LY PARNES H
Citation: Ly. Gong et H. Parnes, SUPER HIGH SPECIFIC ACTIVITY TRITIUM-LABELED RECEPTOR LIGANDS .1. THEUSE OF POLYBROMODIPHENYLACETIC ACID AS A TRITIATION SUBSTRATE - SYNTHESIS OF A TRITIUM-LABELED SODIUM-CHANNEL BLOCKER AND ANGIOTENSIN-II ANTAGONIST WITH SUPER HIGH SPECIFIC ACTIVITY, Journal of labelled compounds & radiopharmaceuticals, 38(1), 1996, pp. 31-40
SYNTHESIS OF TRITIUM-LABELED (R)-3-AMINOQUINUCLIDINE AND (S)-3-AMINOQUINUCLIDINE - A UBIQUITOUS COMPONENT OF SEROTONIN RECEPTOR LIGANDS .1.
Authors: MASJEDIZADEH MR PARNES H
Citation: Mr. Masjedizadeh et H. Parnes, SYNTHESIS OF TRITIUM-LABELED (R)-3-AMINOQUINUCLIDINE AND (S)-3-AMINOQUINUCLIDINE - A UBIQUITOUS COMPONENT OF SEROTONIN RECEPTOR LIGANDS .1., Journal of labelled compounds & radiopharmaceuticals, 38(1), 1996, pp. 41-51
SYNTHESIS OF TRITIUM-LABELED (R)-3-AMINOQUINUCLIDINE AND (S)-3-AMINOQUINUCLIDINE - A UBIQUITOUS COMPONENT OF SEROTONIN RECEPTOR LIGANDS .2.
Authors: MASJEDIZADEH MR PARNES H
Citation: Mr. Masjedizadeh et H. Parnes, SYNTHESIS OF TRITIUM-LABELED (R)-3-AMINOQUINUCLIDINE AND (S)-3-AMINOQUINUCLIDINE - A UBIQUITOUS COMPONENT OF SEROTONIN RECEPTOR LIGANDS .2., Journal of labelled compounds & radiopharmaceuticals, 38(1), 1996, pp. 53-60
SYNTHESIS OF [4,6-H-3]-2-PYRIDONE AND [H-3] RS-91309
Authors: DEKECZER S PARNES H
Citation: S. Dekeczer et H. Parnes, SYNTHESIS OF [4,6-H-3]-2-PYRIDONE AND [H-3] RS-91309, Journal of labelled compounds & radiopharmaceuticals, 36(8), 1995, pp. 765-772
SYNTHESIS OF MYCOPHENOLATE MOFETIL-[C-14], RS-61443-C-14
Authors: HUANG GT PARNES H
Citation: Gt. Huang et H. Parnes, SYNTHESIS OF MYCOPHENOLATE MOFETIL-[C-14], RS-61443-C-14, Journal of labelled compounds & radiopharmaceuticals, 36(5), 1995, pp. 449-456
SYNTHESIS OF THE ANTIINFLAMMATORY PRODRUG RS-42169-C-14
Authors: PARNES H HUANG GT
Citation: H. Parnes et Gt. Huang, SYNTHESIS OF THE ANTIINFLAMMATORY PRODRUG RS-42169-C-14, Journal of labelled compounds & radiopharmaceuticals, 36(1), 1995, pp. 51-56
PHASE-I TRIAL OF CHLOROGUINOXALINE SULFONAMIDE, WITH CORRELATION OF ITS PHARMACOKINETICS AND PHARMACODYNAMICS
Authors: CONLEY BA OHARA S WU SL MELINK TJ PARNES H PARDOE E EGORIN MJ VANECHO DA
Citation: Ba. Conley et al., PHASE-I TRIAL OF CHLOROGUINOXALINE SULFONAMIDE, WITH CORRELATION OF ITS PHARMACOKINETICS AND PHARMACODYNAMICS, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 139-149
[H-3] RS-45041-190, A POTENT AND SELECTIVE RADIOLIGAND FOR I-2 IMIDAZOLINE RECEPTORS
Authors: MACKINNON AC PARNES H BROWN CM
Citation: Ac. Mackinnon et al., [H-3] RS-45041-190, A POTENT AND SELECTIVE RADIOLIGAND FOR I-2 IMIDAZOLINE RECEPTORS, British Journal of Pharmacology, 115, 1995, pp. 32-32
5-HYDROXYTRYPTAMINE (5-HT)(4) RECEPTORS IN POST-MORTEM HUMAN BRAIN-TISSUE - DISTRIBUTION, PHARMACOLOGY AND EFFECTS OF NEURODEGENERATIVE DISEASES
Authors: REYNOLDS GP MASON SL MELDRUM A DEKECZER S PARNES H EGLEN RM WONG EHF
Citation: Gp. Reynolds et al., 5-HYDROXYTRYPTAMINE (5-HT)(4) RECEPTORS IN POST-MORTEM HUMAN BRAIN-TISSUE - DISTRIBUTION, PHARMACOLOGY AND EFFECTS OF NEURODEGENERATIVE DISEASES, British Journal of Pharmacology, 114(5), 1995, pp. 993-998
THE INTERACTION OF RS-25259-197, A POTENT AND SELECTIVE ANTAGONIST, WITH 5-HT3 RECEPTORS, IN-VITRO
Authors: WONG EHF CLARK R LEUNG E LOURY D BONHAUS DW JAKEMAN L PARNES H WHITING RL EGLEN RM
Citation: Ehf. Wong et al., THE INTERACTION OF RS-25259-197, A POTENT AND SELECTIVE ANTAGONIST, WITH 5-HT3 RECEPTORS, IN-VITRO, British Journal of Pharmacology, 114(4), 1995, pp. 851-859
[H-3] GR113808 BINDING TO 5-HT4 RECEPTORS IN HUMAN NEURODEGENERATIVE DISORDERS
Authors: REYNOLDS GP MASON SL MELDRUM A DEKECZER S PARNES H EGLEN RM WONG EHF
Citation: Gp. Reynolds et al., [H-3] GR113808 BINDING TO 5-HT4 RECEPTORS IN HUMAN NEURODEGENERATIVE DISORDERS, British Journal of Pharmacology, 112, 1994, pp. 210000115-210000115
CHARACTERIZATION OF THE DISTRIBUTION OF 5-HT4 RECEPTORS IN HUMAN BRAIN USING [H-3] GR113808
Authors: REYNOLDS GP MASON SL MELDRUM A DEKECZER S PARNES H EGLEN RM WONG EHF
Citation: Gp. Reynolds et al., CHARACTERIZATION OF THE DISTRIBUTION OF 5-HT4 RECEPTORS IN HUMAN BRAIN USING [H-3] GR113808, British Journal of Pharmacology, 112, 1994, pp. 210000153-210000153
SYNTHESIS OF THE SEROTONIN LIGANDS, RS-56532-C-14 AND RS-66331-C-14 FROM A COMMON LABELED INTERMEDIATE
Authors: MASJEDIZADEH MR PARNES H
Citation: Mr. Masjedizadeh et H. Parnes, SYNTHESIS OF THE SEROTONIN LIGANDS, RS-56532-C-14 AND RS-66331-C-14 FROM A COMMON LABELED INTERMEDIATE, Journal of labelled compounds & radiopharmaceuticals, 33(8), 1993, pp. 687-696
Risultati: 1-17 |